Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HOLISTA COLLTECH LIMITED Capital/Financing Update 2020

Jun 11, 2020

65044_rns_2020-06-11_81efb9aa-9407-4dab-9f2e-1fae2a1386e0.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [215 x 49] intentionally omitted <==

Holista CollTech Limited (ASX:HCT / ABN 24 094 515 992) 283 Rokeby Road Subiaco WA 6008 P: +61 8 6141 3500; F: +61 8 6141 3599 W: www.holistaco.com

ASX Announcement

12[th] June 2020

Holista Acquires Protectene™, to Add Advanced Skin Ingredient to Its Range of Sanitising Products Under Natshield™

Highlights

  • Global Infection Control transfers unique skin based technology to Holista

  • Protectene™ works better and longer on the skin and is more suited for sensitive skin membranes like nasal membranes

  • To be used as an ingredient in current and future products

Holista Colltech (ASX:HCT, “Holista”) refers to its previous announcements in relation to the NatShield™ sanitiser developed and marketed by the company which includes the alcohol-free and plant-based Path-Away® active ingredient developed by Global Infection Control Consultants (“GICC LLC”).

Holista is pleased to announce that it has fully acquired the technology of Protectene™, a skin stabiliser for cosmetic applications that incorporates Path-Away® from GICC LLC. Protectene® is a special formulation that lasts longer and is more gentler on the skin while maintaining all the basic features of Path-Away® . Holista will now own the trademark Protectene™ and all the rights to use it including the domains.

Protectene™ has been developed to sanitise the human skin including the face and nasal membranes, making it relevant for the nasal balm under development It also lasts longer on the skin surface as it creates a biofilm on the skin’s surface for longer sanitisation.

While Protectene™ will now be held exclusively by Holista, it will still be manufactured by GICC LLC at its exclusive facility in Bluffton, South Carolina. Protectene™ will be included in all future formulations of NatShield™ for personal use, including the nasal sanitising balm.

In consideration for the transfer of the technology of Protectene™, Holista intends to grant GICC LLC 2,000,000 options in HCT, with an exercise price of A$0.20 each and expiring 31 December 2020. This is subject to shareholder approval at the upcoming Annual General Meeting, likely to be in the last week of July.

“While Path-Away® has applications for a myriad of uses – human, veterinary, agricultural and environmental – and spans many industries, Protectene™ is designed specifically for human skin, making it ideal for those with sensitive skin or part of the human body such as nasal membranes,” said Dr Arthur V. Martin, President of GICC LLC.

“We intend to offer Protectene™ as a more specialised ingredient that uses it exclusively for the NatShield™ brand . We are confident that Protectene® will be a unique differentiator” , said Dr. Rajen Manicka, CEO of Holista.

Natshield containing Path-Away® has been proven 99.99% effective against the surrogate of COVID19 - the feline coronavirus. The all-natural alcohol-free solution was tested in one of the U.K’s leading microbiology labs (Refer to ASX Announcement dated 20 April 2020, titled ‘Successful UK Lab tests’).

#END#

About Holista CollTech Ltd

Holista CollTech Ltd (“Holista”) is a natural wellness company, the result of a merger between Holista Biotech Sdn Bhd and CollTech Australia Ltd. The company has 3 main divisions:

  • Dietary supplements and personal care

  • Food Ingredients

  • Ovine collagen

Holista has a global collaboration with Path-Away®, a plant-based solution that is proven to kill a board spectrum of microbes. The all-natural alcohol-free solution is an active ingredient in Holista’s proprietary hand sanitiser, NatShield™ that is sold under its personal care space.

Listed on the Australian Securities Exchange (“ASX”), Holista researches, develops, manufactures and markets “health-style” products to address the unmet and evolving needs of natural medicine. Holista’s suite of ingredients includes low-GI baked products, reduced-sodium salts, low-fat fried foods and low-calorie sugar without compromising taste, odour and mouthfeel. Holista remains the only company to produce sheep (ovine) collagen using patented extraction methods.

For more information, please refer to http://www.holistaco.com

For further information, please contact:

Corporate Affairs & Business Opportunities

Corporate Matters: [email protected] General Enquiries: [email protected]

Australia

283 Rokeby Road Subiaco WA 6008 P: +61 8 6141 3500 ; F: +61 8 6141 3599

Malaysia

12th Floor, Amcorp Trade Centre, PJ Tower No. 18, Persiaran Barat off Jalan Timur 46000, Petaling Jaya, Malaysia

P: +603 7965 2828 ; F: +603 7965 2777

Media Contact

WeR1 Consultants Pte Ltd

E: [email protected]

P: +65 67374844